Welcome to Bio Basic Asia Pacific Pte Ltd
This website uses cookies to ensure the best experience. By continuing, you agree to our Privacy Policy.
For decades, PCR cloning has served as the standard approach for generating DNA constructs in molecular biology laboratories. While researchers traditionally amplify a gene using PCR and clone the fragment into a vector, the emergence of gene synthesis now offers a more direct, automated alternative.
These technical advances have fundamentally changed how many laboratories approach DNA construction. Instead of relying on existing templates and multiple cloning steps, researchers can now order fully designed DNA sequences produced directly through de novo methods.
For many modern research workflows, the key question is no longer whether the technology works, but whether it can save time compared with traditional PCR cloning. In many cases, the answer is yes.
PCR cloning involves amplifying a DNA fragment from an existing template using polymerase chain reaction. The amplified fragment is then inserted into a plasmid vector using restriction enzymes or other cloning strategies.
A typical PCR cloning workflow includes several steps:
Although this method is widely used, each step introduces potential points of failure. Troubleshooting PCR amplification or cloning efficiency can add days or even weeks to a project.
This technology takes a completely different approach. Instead of amplifying DNA from an existing template, scientists design the desired sequence and chemically construct it from individual nucleotides.
The process assembles short DNA fragments into a full sequence, which the laboratory then verifies and delivers to the researcher, often cloned into a vector if required.
Because the design specifications drive the build process, this method allows researchers to create:
This flexibility has made gene synthesis an increasingly popular alternative to traditional cloning.
One of the main reasons researchers are turning to gene synthesis is time efficiency.
In ideal conditions, PCR cloning can take around one to two weeks to complete. However, this assumes that every step works on the first attempt.
Common delays include:
Each troubleshooting cycle may add several additional days.
With de novo methods, the workflow eliminates many of these intermediate steps. Researchers simply submit the desired sequence and receive the finished DNA construct after synthesis and verification.
Because the gene is built directly according to the design, there is no need to optimise PCR conditions or screen large numbers of colonies.
For complex constructs or synthetic variants, gene synthesis can significantly shorten the overall project timeline.
Despite the advantages of gene synthesis, PCR cloning still has its place in many laboratories.
PCR cloning may be preferable when:
For small, simple cloning tasks, PCR can remain a practical option.
However, as sequence complexity increases, the advantages of gene synthesis become more apparent.
Several research scenarios strongly favour de novo methods over PCR cloning.
PCR cloning relies on an existing template. If the desired sequence contains many mutations or modifications, generating it through PCR can be difficult.
Gene synthesis allows researchers to create fully customised sequences without needing a template.
Genes with high GC content or repetitive regions are often difficult to amplify using PCR. These sequences can form secondary structures that disrupt polymerase activity.
Gene synthesis technologies are designed to handle these complex sequences more reliably.
Introducing several mutations using PCR typically requires multiple rounds of mutagenesis.
With gene synthesis, the final sequence can be designed with all required mutations already included.
When expressing genes in heterologous systems, codon optimisation is often required.
Instead of modifying the gene through several cloning steps, gene synthesis allows the sequence to be optimised directly during the design stage.
Advances in synthetic biology have made gene synthesis a central tool in modern molecular biology.
Researchers now use synthetic genes for:
As the field continues to evolve, these methods deliver faster, more reliable, and more accessible solutions to laboratories worldwide.
At Bio Basic Asia Pacific, we specialise in de novo gene synthesis for research laboratories. With around 20 years of experience in the field, our team synthesises thousands of genes each month for molecular biology and biotechnology applications.
Our synthesis capabilities cover gene lengths ranging from approximately 10 base pairs to more than 10,000 base pairs, including sequences with complex structures such as high GC content or repetitive elements.
We also provide a range of related services, including:
With a 99.9 percent delivery rate, our team works to ensure researchers receive reliable gene constructs that support their next discovery.
PCR cloning has served molecular biology for many years, but it often involves multiple steps and frequent troubleshooting. For modern research workflows, gene synthesis offers a faster and more flexible alternative.
By removing the need for template DNA, PCR optimisation, and cloning screens, this approach allows researchers to move directly from sequence design to functional experiments.
For laboratories aiming to accelerate their research timelines, the technology has become an increasingly practical way to move projects forward with fewer delays